Camden, NJ. April 2023: New Jersey’s Commission on Science, Innovation, and Technology (CSIT) recently organized a valuable event at Rutgers and Rowan University’s Translational Research Facility in Camden, NJ during the last quarter. Delphine Diagnostics was invited to participate in this state-level round table discussion to address pressing issues and challenges facing the life sciences ecosystem.
During the discussion, two key topics were explored:
Q1: Support from the State – What specific type of support would be most impactful for companies like Delphine Diagnostics to grow their business in New Jersey?
Q2: Talent Acquisition – What specific positions do companies like Delphine Diagnostics need to fill for current vacancies and projected future hiring needs to support their growth?
After the discussion, a follow-up communication was shared earlier this month, which included actionable items to address the concerns raised during the round table. Overall, the event proved to be a valuable opportunity for Delphine Diagnostics and other life sciences companies to engage with CSIT and discuss critical issues facing their industry in New Jersey.
Delphine Diagnostics is very grateful to the Executive Leadership and Organizing Committee Members of NJ CSIT, NJ EDA, and NJ DOL for their efforts in organizing this valuable event. It’s clear that this is a positive trend and the engaging and value-add conversation provided an excellent opportunity for industry leaders to come together and discuss critical issues facing the life sciences ecosystem in New Jersey.
The collaborative efforts of these organizations are appreciated and demonstrate a commitment to supporting companies like Delphine Diagnostics as they work to grow and develop within the state. We are grateful for the opportunity to participate in this round table discussion and look forward to continued engagement with NJ CSIT, NJ EDA, and NJ DOL in the future.
